A
Study of HIV Disease Course Among Rural Women Receiving ART
Gayathri V1, Ramanamma VM2
1Gayathri Veluri, Associate Professor in Microbiology Department of
Microbiology, NRI Institute of Medical Sciences, Sanghivalasa,
Visakhapatnam, Andhra Pradesh, India
and 2Ramanamma.VenkataMallajosyula, MD (Microbiology) Rector ,
Dr.NTR University of Health Sciences, Vijayawada – 520008,
Andhra Pradesh, India.
Address for
correspondence: Dr Gayathri Veluri, Email:
drgayathrimicro@gmail.com
Abstract
Introduction:
The present study is an attempt to evaluate and document HIV incidence
and progression among women in and around Srikakulam, a remote town in
the north coastal Andhra Pradesh. The results throw light on a greater
effort required to be mobilized towards preventive and therapeutic care
in women in rural areas. Material
& Methods: This is a retrospective study, using
the data collected from ICTC (from April 2007 to March 2011) and ART
center (from April 2007 to February 2010) of RIMS General Hospital,
Srikakulam. The study is focused on the development of CD4 counts at
regular intervals among women on ART. Opportunistic infections, deaths,
transfers and the profiles of CD4 counts have also been analyzed. Results: There is a+
significant percentage of responsiveness to therapy in the younger age
group. Tuberculosis is significant in being the commonest opportunistic
infection causing death with a percentage of 16.4. Maximum number of
deaths (27.8 %) were associated with CD4 counts as low as 0 –
50 per cu mm, and there is a decrease in the percentages of deaths at
higher range of CD4 counts. As a baseline parameter, the CD4 counts of
50 HIV seronegative women between the ages of 15-45 years are
estimated. The average is 972 cells /cumm. Conclusion: In spite
of an overall decrease in the severity of the epidemic, the problem
persists among women in the rural set up. The present study throws
light on the need of special programmes which focus on early detection,
early initiation of ART, counseling regarding barrier methods
applicable to females and monitoring therapy in women.
Key Words:
HumanImmuno Deficiency Virus, Anti Retro Viral Therapy, Integrated
Counseling and Testing Center ( ICTC) CD4 counts, National AIDS Control
Organisation ( NACO),Opportunistic infections (OI), Highly active anti
retro viral therapy (HAART).
Manuscript received: 10th
Sep 2013, Reviewed: 16th
Sep 2013
Author Corrected:
30th Sep 2013, Accepted
for Publication: 1st Oct 2013
Introduction
HIV infection in a developing country like India is unique, as the
progressive ill health is projected on a background of poverty and
inadequate medical care. Among the HIV infected, women in India suffer
more on account of social, cultural, economic, biological and clinical
factors which keep females at a higher risk [1]. Women in India are
mostly illiterate and financially depend on others for their nutrition
and health [2]. Majority of HIV seropositive women in India are married
and reported monogamous [3]. Vertical transmission from a
pregnant women to the fetus is well documented [4] . HIV infection
among women is associated with a greater than two fold risk of having
cervical cancer, TB, invasive candidiasis and many other Opportunistic
Infections.
Triple drug therapy (HAART) alone can significantly alter HIV disease
progression. The challenging issues in India are inadequately trained
human resources and the incapacity of the health system to utilize ART
drugs optimally along with inadequate training of health care
personnel, laboratory monitoring and drug distribution. The present
place of study is a small town in the North East of Andhra Pradesh
surrounded by a number of satellite villages and tribal
areas. Anti Retroviral Therapy (ART) centre has been
established in the hospital, in March 2007. As per the NACO guidelines,
all the seropositive individuals are referred to
ART centre, where they are counseled and baseline
CD4 counts are done. Those with CD4 counts of less than
250/mm3 are started on ART and are followed up on regular basis at
every six month interval.
The present retrospective study is undertaken at ART centre, in the
tertiary care hospital. Detailed information was collected about all
women who attended the ART centre from the date of inception, up to 03
visits (one and a half years). All the factors determining
the clinical course of HIV are analyzed.The results of the present
study throw light on the issues to be solved and methodologies to be
developed to contain HIV infection among women in India.
Material
and Methods
The data collected at ICTC and ART Center (April 2007 to
March 2011) is included in the present study. The critical
analysis of the data is focused on the development of CD4 counts at
regular intervals among women on ART. Opportunistic infections, deaths,
transfers and the profiles of CD4 counts have been analyzed.
Due to poor documentation of data, the details regarding HIV status of
spouse and children, occupation/ income and educational status could
not be obtained.
Results
Table 1: Year wise percentage of HIV
seropositivity among women
Year
|
No of women attending ICTC
|
No of women Positive for HIV
|
% Positivity
|
2007- 2008
Apr - Mar
|
1569
|
333
|
21.22
|
2008- 2009
Apr- Mar
|
1352
|
342
|
25.3
|
2009- 2010
Apr- Mar
|
2495
|
362
|
14.5
|
2010- 2011
Apr- Mar
|
2329
|
295
|
12.66
|
The year wise attendance of women to ICTC and their HIV sero positivity
are shown in Table– I. There is a significant
increase in the attendance over the period of 04 years.
However the percentage of sero positivity has declined significantly as
shown in the 4th column of Table –1.
Table 2: Age
wise & Progress wise distribution of women on ART
S. No |
Age Group |
Total No of women on ART |
Women with
Increasing CD4 counts
No / % |
Women with
Decreasing CD4 counts
No / % |
Deaths No / % |
Transfer No / % |
1 |
15
- 25 |
267 |
216
80.90 |
7
2.6 |
28
10.50 |
16
6 |
2 |
26
- 35 |
653 |
531
81.30 |
7
1.30 |
95
14.50 |
20
3 |
3 |
36
- 45 |
337 |
262
77.70 |
11
3.30 |
55
16.30 |
9
2.70 |
4 |
>45 |
90 |
67
74.40 |
5
5.50 |
17
18.90 |
1
1.10 |
chi-square value 10.903, p<0.02.
In Table – 2, women on ART are studied in different
age groups among whom redistribution was done based on increasing and
decreasing CD4 counts, deaths and transfers. There is a
significant percentage of responsiveness to therapy in the younger age
groups (15-25 years and 26-35 years ) evidenced by increasing CD4
counts.
Table 3: Opportunistic
infections among deaths while on ART
Sl.
No
|
Cause of Death
|
No. of deaths
|
Percentage
|
1
|
Tuberculosis
|
32
|
16.4
|
2
|
Ari
|
27
|
13.8
|
3
|
Jaundice
|
27
|
13.8
|
4
|
Diarrhoea
|
21
|
10.8
|
5
|
Candidiasis
|
15
|
7.7
|
6
|
Gross anemia
|
25
|
12.8
|
7
|
Not documented
|
48
|
24.6
|
8
|
Total no of Deaths
|
195
|
100
|
Chi square test 23.15, p<0.005, Significant.
Table – 3 depicts the range of opportunistic infections
recorded as cause of death among patients while on ART. Tuberculosis is
significant in being the commonest opportunistic infection, with a
percentage of 16.4. Acute respiratory infection as cause of death
accounted for 13.8%. Jaundice is documented in 13.8% of cases. However
the etiological diagnosis has not been made. The percentages are
represented in Figure-1.
Table 4:
Comparison of percentages of deaths at various ranges of CD4 Counts
Sr. No
|
Range of CD 4 count (no/cumm)
|
Number of deaths
|
Percentage
|
1
|
0 -50
|
53
|
27.18
|
2
|
51 – 100
|
35
|
17.9
|
3
|
101 – 150
|
28
|
14.36
|
4
|
151- 200
|
33
|
16.92
|
5
|
201- 250
|
20
|
10.26
|
6
|
251 – 300
|
14
|
7.18
|
7
|
>300
|
12
|
6.15
|
In Table – 4, an attempt is made to tabulate the ranges of
CD4 counts among patients who died while on ART. Maximum number of
deaths (27.18%) were associated with counts as low as 0-50. Deaths
occurred even at CD4 counts above 200, as shown in the table.
However, there is a gradual decrease in the percentages of deaths at
higher range of CD4 counts. As a baseline parameter, the CD4count of 50
HIV seronegative women between the ages of 15-45 years are
estimated. The average is 972 cells / mm3, which is
correlating with Murugavel et al [5, a study done in healthy adult
population in Chennai, India.
Discussion
Since more than two decades, the AIDS pandemic in India has grown as a
major public health problem with medical, psychosocial and economic
consequences at individual and at national level. The median HIV
prevalence in A.P. is 1.25% in low risk groups, being higher than all
the other states in India [6]. Apart from factors such as
sexual practices, the other risk factors in females are male
– female age differences, anatomical peculiarity of
genitalia, asymptomatic S.T.Ds in women, blood transfusions etc. In
India, women are in a poor position to question their husbands about
their extramarital encounters, to negotiate condom use or refuse to
have sex. Forced sexual encounters invariably end in bruises and
injuries to genitalia, favoring transmission of HIV.
Percentage of HIV seropositivity among women attending ICTC has a
gradual decline, from 21.2% to 12.7%. This is in coincidence with the
control of HIV epidemic in India with effective national policies as
well as involvement of voluntary organisations in the control of the
epidemic. More awareness regarding HIV is another reason responsible
for large number of person are coming for volunteer testing. CD4 cells
are the major cell types affected. ART reconstitutes the immune system
and improves survival [7]. However the rate and extent of CD4
+ T cell recovery varies widely. In the present
study (Table-II), a significant improvement of CD4 counts is observed
in the younger age groups 15-25 years and 26-35 years. The
percentage of older women who have responded to ART by increasing CD4
counts is however less compared to the younger age group.
For reasons which are yet to be identified, younger women responded
better than older women to ART as per the data. According to Shaeferet
al [8], younger patients have a significantly larger increase in CD4
cells after 48 weeks of ART. This is probably related to a better
functioning immune system in the young, reacting positively to
compensate for the depleting CD4 cells. Such mechanism may not be
possible as age advances, due to decompensated immune system.
In the present study tuberculosis occupied the first place with
a percentage of 16.4% as the commonest Opportunistic
Infection causing death in HIV positive individuals while
still on ART. As already documented, TB- HIV confection is a
major world health problem and according to WHO, nearly a quarter of
the HIV deaths were due to tuberculosis in 2007. In
developing countries like India, tuberculosis presents as a pulmonary
disease. It is also a well documented fact that the most
common OI in HIV infected is pulmonary tuberculosis [9]. Risk
of death in HIV- TB patients is 3.5 times greater than the risk in HIV
positive patients without TB with matched CD4 counts [10]. In
other countries like Uganda, HIV- TB was 1.4 % among the total HIV
infected patients [11]. In a study at Baltimore, USA, the
incidence of HIV- TB was 3.6% [12]. A study in Sub Saharan Africa [13]
has shown that HIV - TB patients have a significantly lower median CD4
count increase, compared to the non TB counterparts while on ART.
In the present study (Table – IV), as much as 27.18% of
deaths while on ART occurred with a CD4 count range of 0
– 50 cells / mm3. The number and percentage of
deaths were lower at higher ranges of CD4 counts. Literature
is not available regarding the average CD4 counts at the time of death
of Indian patients on ART. However, it can be stated that the
individual risks and complications associated with Opportunistic
Infection determine the time of death and not CD4 counts alone.
Opportunistic infections always occur at lower CD4 counts, and further
reduce the immune competence of the patients.
Conclusion
There are very few studies on HIV disease among Indian women. In spite
of active intervention by Government Of India and NGOs, only about 80%
of women improved with ART as per the present study. Therefore it might
be stated that special programmes are needed to
focus on early detection, early initiation of ART, counseling regarding
barrier methods applicable to females and above all, monitoring therapy
among women in India to achieve better survival rates with ART.
Funding: Nil,
Conflict of interest: Nil
Permission from IRB: Yes
References
1. Usha KB, Rewari BB. Diagnosis and management of HIV/
AIDS, a clinician’s perspective. 1st ed. B.I Publications
Private Limited; 2004. ch 18 P. 264-279.
2. Gilks CF. Natural history of HIV-AIDS. In: Manson’s
Tropical Diseases.21st ed. W B Saunders: 2003 .Ch 20 P. 411.
3. Gangakhedkar RR, Bentley ME, Divakar AD
.Spread of HIV infection among married monogamous women attending STD
clinics in India . JAMA 1997; 278 : 2090 – 2092. [PubMed]
4. Patubidn VG, Daftary SN. Natural course of HIV. In:
Shaw’s Text Book of Gynecology. 15th ed. Elsevier’s
Publications; 2010. Ch 11: 148.
5. Murugavel KG, Balakrishnan P,
MohankrishnanJ, Solomon SS, Shankar EM ,. Establishment of T-lymphocyte
subject reference intervals in a healthy adult population in Chennai,
India. Indian J Med Res 2009;129:59-63. [PubMed]
6. Usha KB, Rewari BB. Diagnosis and management of HIV/ AIDS, a
clinician’s perspective. 1st ed. B.I publications Private
Limited ; 2004. ch 18 P. 2-9.
7. Wilkins EGL.Humanimmuno deficiency virus
infection and the Human acquired immunodeficiency syndrome.
Davidson’s Principles and Practice of Medicine.20th ed. John
A.A Hunter ,Churchill Livingstone- Elsevier publication 2006;ch14 P.
399-401.
8. Shaefer M, James D, Henry Z, Amy C, Martin G,
James G. Effect of age on baseline CD4+ and CD8+ cells and response to
ART over 48 weeks in a large clinical trial database. Presented at the
1st Int. Workshop on HIV & Aging, 4-5 Oct 2010, Baltimore, USA.
9. Solmon S, Kumarswamy , Anuradha S, Vennila R,
Pal JA. TB and HIV infection – an association. Indian J Med
Microbiol 1994, 12: 313 – 4.
10. Kumarasamy N, Solomon S, Flanigan TP,
Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human
immunodeficiency virus infection among adults in Mumbai. Nat Med J
India 2003;16: 126-31.
11. Nakanjako D, MayanjaKH ,Ouma J , Wanyenze R,
Mwesigine D, Namle A, Sse MJ, Senkusu J, Colebunders R, Kamya MR
:Tuberculosis and human immunodeficiency virus co-infection and their
predictors at a hospital based HIV/AIDS clinic in Uganda. Int J Tuberc
lung Dis 2010;14: 1621-8.
12. Martinson NA, Barnes GL, Moultion LH,
Msandiwa R, Hausler H, Ram M, Mclntyre JA, . New regimens to prevent
tuberculosis in adults with HIV infection. N Eng J Med 2011; 365 (1)
;11-20. [PubMed]
13. Hermans SM, Kiragga AN, Schafer P, Kambugu
A, Hoepelman A1, Manabe YC. Incident tuberculosis during antiretroviral
therapy contributes to suboptimal immune reconstitution in a large
urban HIV clinic in sub-saharan
Africa.http://blogs.plos.org/plos/2010/10/epigenetics-2010-a-new-collection-from-the-plos-journals/.
How to cite this article?
Gayathri V, Ramanamma VM. A Study of HIV Disease Course Among Rural
Women Receiving ART. Int J Med Res Rev 2013;1(4).doi:10.17511/ijmrr.2013.i04.007.